Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Betaxolol adverse reaction |
Causative agent (attribute) |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to betaxolol |
Causative agent (attribute) |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betaxolol HCl [b-blocker] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betaxolol hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betaxolol hydrochloride [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betaxolol 0.25% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betaxolol 0.25% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betaxolol (as betaxolol hydrochloride) 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betaxolol hydrochloride (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betaxolol hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betaxolol hydrochloride 0.25% suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betaxolol hydrochloride 0.5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betaxolol hydrochloride 2.5mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ophthalmic betaxolol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to betaxolol |
Causative agent (attribute) |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betaxolol hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betaxolol hydrochloride 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betaxolol hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betaxolol hydrochloride 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betaxolol hydrochloride 10 mg oral tablet |
Has precise active ingredient |
True |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betaxolol hydrochloride 20 mg oral tablet |
Has precise active ingredient |
True |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betaxolol 0.25% eye drops (substance) |
Has precise active ingredient |
True |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betaxolol (as betaxolol hydrochloride) 5 mg/mL eye drops |
Has precise active ingredient |
True |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Betaxolol 0.25% conventional release eye drops |
Has precise active ingredient |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Has basis of strength substance (attribute) |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Has precise active ingredient |
False |
Betaxolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |